线粒体DNA变异与原发性开角型青光眼易感性
该病例对照研究对90例原发性开角型青光眼患者和95例年龄性别匹配的人群对照进行线粒体DNA全序列测序,发现欧洲人群线粒体单倍群U在男性患者中显著减少,MT-ND2基因变异在对照组中富集,提示线粒体DNA谱系可能调节原发性开角型青光眼风险。
要点
- 线粒体单倍群U在男性原发性开角型青光眼患者中显著减少。
- MT-ND2基因变异在对照组中富集,可能具有保护作用。
- 线粒体DNA祖系可能调节欧洲人群原发性开角型青光眼风险。
核心结论
- 线粒体DNA祖系调节欧洲人群原发性开角型青光眼的风险。
- 单倍群U和MT-ND2基因的罕见变异可能对原发性开角型青光眼具有保护作用。
研究设计与样本
- 病例对照研究,纳入90例原发性开角型青光眼患者和95例年龄性别匹配的人群对照。
- 采用下一代测序技术对外周血线粒体DNA全序列进行测序,并与修订版剑桥参考序列比较以定义单倍群和变异。
主要发现
- 多数受试者属于欧洲主要单倍群H、J、K、U和T。
- 逻辑回归分析显示单倍群U在男性原发性开角型青光眼患者中显著减少(比值比0.25;95%置信区间0.09-0.67;P=0.007;Bonferroni多重检验P=0.022)。
- 线粒体DNA基因MT-ND2的变异在对照组中富集(P=0.005;Bonferroni多重检验校正P=0.015)。
关键数值与推荐
- 单倍群U与男性原发性开角型青光眼负相关:比值比0.25(95%置信区间0.09-0.67),P=0.007,Bonferroni多重检验P=0.022。
- MT-ND2基因变异在对照组中富集:P=0.005,Bonferroni多重检验校正P=0.015。
临床怎么用
- 线粒体DNA单倍群和MT-ND2变异可能作为原发性开角型青光眼风险分层的潜在生物标志物。
- 需更大规模研究探索不同种族中线粒体单倍群与疾病风险的关联,并定义原发性开角型青光眼内表型的生物标志物以指导治疗策略。
局限性
- 样本量较小(90例患者和95例对照),需更大规模研究验证。
- 研究人群限于欧洲裔,结论外推至其他种族需谨慎。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
PURPOSE: To determine whether mitochondrial DNA haplogroups or rare variants associate with primary open-angle glaucoma in subjects of European descent. METHODS: A case-control comparison of age- and sex-matched cohorts of 90 primary open-angle glaucoma patients and 95 population controls. Full mitochondrial DNA sequences from peripheral blood were generated by next-generation sequencing and compared to the revised Cambridge Reference Sequence to define mitochondrial haplogroups and variants. RESULTS: Most subjects were of the major European haplogroups H, J, K, U, and T. Logistic regression analysis showed haplogroup U to be significantly underrepresented in male primary open-angle glaucoma subjects (odds ratio 0.25; 95% confidence interval [CI] 0.09-0.67; P = 0.007; Bonferroni multiple testing P = 0.022). Variants in the mitochondrial DNA gene MT-ND2 were overrepresented in the control group (P = 0.005; Bonferroni multiple testing correction P = 0.015). CONCLUSIONS: Mitochondrial DNA ancestral lineages modulate the risk for primary open-angle glaucoma in populations of European descent. Haplogroup U and rare variants in the mitochondrial DNA-encoded MT-ND2 gene may be protective against primary open-angle glaucoma. Larger studies are warranted to explore haplogroup associations with disease risk in different ethnic groups and define biomarkers of primary open-angle glaucoma endophenotypes to target therapeutic strategies.
引用
- Singh LN, Crowston JG, Lopez Sanchez MIG, et al. Mitochondrial DNA Variation and Disease Susceptibility in Primary Open-Angle Glaucoma. Invest Ophthalmol Vis Sci. 2018. PMID: 30242360. doi:10.1167/iovs.18-25085
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。